✦ LIBER ✦
Final results of the EORTC 18871/DKG 80-1 randomised phase III trial: rIFN-α2b versus rIFN-γ versus ISCADOR M® versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasis
✍ Scribed by U.R. Kleeberg; S. Suciu; E.B. Bröcker; D.J. Ruiter; C. Chartier; D. Liénard; J. Marsden; D. Schadendorf; A.M.M. Eggermont
- Book ID
- 116427941
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 292 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.